Acceleron Pharma Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
57,230.00
14,632.00
18,097.00
27,771.00
13,481.00
13,991
Cost of Goods Sold (COGS) incl. D&A
915.00
-
-
-
-
-
Gross Income
56,315.00
-
-
-
-
-
SG&A Expense
49,363.00
63,978.00
77,800.00
92,201.00
120,639.00
134,658
EBIT
6,952.00
50,464.00
60,879.00
66,106.00
109,983.00
124,414
Unusual Expense
26,875.00
10,037.00
3,527.00
7,262.00
992.00
52
Non Operating Income/Expense
78.00
10,081.00
-
-
-
-
Interest Expense
2,092.00
922.00
-
-
-
-
Pretax Income
21,898.00
51,259.00
63,894.00
56,990.00
108,422.00
118,898
Income Tax
-
-
-
24.00
32.00
27
Consolidated Net Income
41,768.00
51,259.00
63,894.00
57,014.00
108,454.00
118,871
Net Income
41,768.00
51,259.00
63,894.00
57,014.00
108,454.00
118,871
Net Income After Extraordinaries
44,533.00
51,259.00
63,894.00
57,014.00
108,454.00
118,871
Net Income Available to Common
41,768.00
51,259.00
63,894.00
57,014.00
108,454.00
118,871
EPS (Basic)
4.15
1.63
1.92
1.52
2.68
2.59
Basic Shares Outstanding
9,407.00
31,515.00
33,303.00
37,430.00
40,420.00
45,898
EPS (Diluted)
4.15
1.63
1.92
1.52
2.68
2.59
Diluted Shares Outstanding
9,407.00
31,515.00
33,303.00
37,430.00
40,420.00
45,898
EBITDA
7,867.00
49,346.00
59,703.00
64,430.00
107,158.00
120,667
Non-Operating Interest Income
39.00
83.00
512.00
1,854.00
2,553.00
5,568
Other After Tax Income (Expense)
19,870.00
-
-
-
-
-
About Acceleron Pharma
View Profile
